85 related articles for article (PubMed ID: 22773158)
21. Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development.
Ekins S; Williams AJ
Lab Chip; 2010 Jan; 10(1):13-22. PubMed ID: 20024044
[TBL] [Abstract][Full Text] [Related]
22. Principles of pharmacodynamics and their applications in veterinary pharmacology.
Lees P; Cunningham FM; Elliott J
J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
[TBL] [Abstract][Full Text] [Related]
23. A novel platform for accelerated pharmacodynamic profiling for lead optimization of anticancer drug candidates.
Szwaya J; Bruseo C; Nakuci E; McSweeney D; Xiang X; Senator D; France D; Chen CR
J Biomol Screen; 2007 Mar; 12(2):159-66. PubMed ID: 17259588
[TBL] [Abstract][Full Text] [Related]
24. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
Farenc C; Fabreguette JR; Bressolle F
Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
[TBL] [Abstract][Full Text] [Related]
25. Analysis of pharmacokinetics, pharmacodynamics, and pharmacogenomics data sets using VizStruct, a novel multidimensional visualization technique.
Bhasi K; Zhang L; Zhang A; Ramanathan M
Pharm Res; 2004 May; 21(5):777-80. PubMed ID: 15180333
[TBL] [Abstract][Full Text] [Related]
26. Strategies for conducting ADME studies during lead generation in the drug discovery process.
Cramer JW; Mattioni BE; Savin KA
IDrugs; 2010 Dec; 13(12):857-61. PubMed ID: 21154143
[TBL] [Abstract][Full Text] [Related]
27. Data mining for chinese materia medica and pharmacological research.
Tse HY; Li VW; Hui MN; Kwok Chan P; Han Cheng S
J Biomol Screen; 2008 Jun; 13(5):390-5. PubMed ID: 18443208
[TBL] [Abstract][Full Text] [Related]
28. Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies.
Isin EM; Elmore CS; Nilsson GN; Thompson RA; Weidolf L
Chem Res Toxicol; 2012 Mar; 25(3):532-42. PubMed ID: 22372867
[TBL] [Abstract][Full Text] [Related]
29. Strategies for bringing drug delivery tools into discovery.
Kwong E; Higgins J; Templeton AC
Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040
[TBL] [Abstract][Full Text] [Related]
30. [A drug computer database].
Buchatskiĭ AG; Kazachenko KIu; Aleksandrov AA
Biofizika; 2003; 48(1):133-8. PubMed ID: 12701626
[No Abstract] [Full Text] [Related]
31. PhRMA survey of pharmacogenomic and pharmacodynamic evaluations: what next?
Grecco N; Cohen N; Warner AW; Lopez-Correa C; Truter SL; Snapir A; Piccoli SP; Wang D; Westelinck A; Hinman L; Franc MA;
Clin Pharmacol Ther; 2012 Jun; 91(6):1035-43. PubMed ID: 22534869
[TBL] [Abstract][Full Text] [Related]
32. Regulatory science as a bridge between science and society.
Tominaga T; Asahina Y; Uyama Y; Kondo T
Clin Pharmacol Ther; 2011 Jul; 90(1):29-31. PubMed ID: 21691273
[TBL] [Abstract][Full Text] [Related]
33. A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development.
Rocchetti M; Poggesi I; Germani M; Fiorentini F; Pellizzoni C; Zugnoni P; Pesenti E; Simeoni M; De Nicolao G
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):265-8. PubMed ID: 15733231
[No Abstract] [Full Text] [Related]
34. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
35. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
Xu EY; Schaefer WH; Xu Q
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
[TBL] [Abstract][Full Text] [Related]
37. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
Allerheiligen SR
Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract][Full Text] [Related]
39. Development of a Virtual Private Database for a multi-institutional Internet-based Radiation Oncology Database overcoming differences in protocols.
Harauchi H; Kondo T; Kumasaki Y; Ishibashi M; Numasaki H; Kou H; Okura Y; Umeda T; Takemura A; Inamura K
Igaku Butsuri; 2002; 22(2):125-33. PubMed ID: 12766290
[TBL] [Abstract][Full Text] [Related]
40. Models for assessing the relationship between drug concentration and drug effect in performance horses.
Kamerling SG; Owens JG
Br Vet J; 1994; 150(6):507-25. PubMed ID: 7850442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
